Skip to main content
BrainCited
Figure 7

Описание

Evidence summary on the association between specific carotenoid compounds and Alzheimer's disease biomarkers. The data suggest that higher carotenoid status may be linked to reduced oxidative damage in neural tissues.

More Figures from This Paper

Introductory overview of the carotenoid compounds evaluated for neuroprotective effects in Alzheimer's disease. The review examines how these dietary pigments may counteract neurodegeneration through antioxidant and anti-inflammatory pathways.

Figure 2

Introductory overview of the carotenoid compounds evaluated for neuroprotective effects in Alzheimer's disease. The review examines how these dietary pigments may counteract neurodegeneration through antioxidant and anti-inflammatory pathways.

diagram
KEGG pathway map (hsa05010) illustrating the molecular cascade involved in Alzheimer's disease pathogenesis in humans. The diagram highlights potential intervention points where carotenoid compounds may modulate amyloid-beta accumulation, tau phosphorylation, and neuroinflammatory signaling.

Figure 3

KEGG pathway map (hsa05010) illustrating the molecular cascade involved in Alzheimer's disease pathogenesis in humans. The diagram highlights potential intervention points where carotenoid compounds may modulate amyloid-beta accumulation, tau phosphorylation, and neuroinflammatory signaling.

diagram
Alpha- and beta-cryptoxanthin serve as provitamin A sources due to their unsubstituted beta-ring structure. The review discusses their potential role in Alzheimer's disease prevention through both antioxidant activity and vitamin A metabolite production in neural tissue.

Figure 22

Alpha- and beta-cryptoxanthin serve as provitamin A sources due to their unsubstituted beta-ring structure. The review discusses their potential role in Alzheimer's disease prevention through both antioxidant activity and vitamin A metabolite production in neural tissue.

diagram

Figure 7

Chart
945 × 412px · 123,3 КБ

Source Paper

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.

International journal of molecular sciences (2024)

PMID: 39201668

DOI: 10.3390/ijms25168982

Cite This Figure

![Figure 7: Evidence summary on the association between specific carotenoid compounds and Alzheimer's disease biomarkers. The data suggest that higher carotenoid status may be linked to reduced oxidative damage in neural tissues.](https://pdfs.citedhealth.com/figures/39201668/320.png)

> Source: Jolanta Flieger et al. "Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.." *International journal of molecular sciences*, 2024. PMID: [39201668](https://pubmed.ncbi.nlm.nih.gov/39201668/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/39201668/320.png" alt="Evidence summary on the association between specific carotenoid compounds and Alzheimer's disease biomarkers. The data suggest that higher carotenoid status may be linked to reduced oxidative damage in neural tissues." />
  <figcaption>Figure 7. Evidence summary on the association between specific carotenoid compounds and Alzheimer's disease biomarkers. The data suggest that higher carotenoid status may be linked to reduced oxidative damage in neural tissues.<br>  Source: Jolanta Flieger et al. "Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.." <em>International journal of molecular sciences</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39201668/">39201668</a></figcaption>
</figure>

Связанные доказательства

C
Lutein & Zeaxanthin для Age-Related Cognitive Decline

Оценка C · 8 исследований